MOH — authorised 27 January 2023
- Marketing authorisation holder: STEMLINE THERAPEUTICS INC
- Status: likely_approved
MOH authorised Orserdu on 27 January 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 27 January 2023.
STEMLINE THERAPEUTICS INC holds the UAE marketing authorisation.